During the past decade, Ningbo No.2 Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ningbo No.2 Hospital" #1 sponsor was "FibroGen" with 2 trials, followed by "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 2 trials sponsored, "BeiGene" with 1 trials sponsored, "Geneplus-Beijing Co. Ltd." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ningbo No.2 Hospital" #1 collaborator was "Beijing Anzhen Hospital" with 1 trials as a collaborator, "First Hospital of China Medical University" with 1 trials as a collaborator, "National Research Institute for Family Planning, China" with 1 trials as a collaborator, "Ningbo No.2 Hospital" with 1 trials as a collaborator and "Shanghai Chest Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ningbo No.2 Hospital" are "Anemia" (2 trials), "Adenocarcinoma of Lung" (1 trials), "Cirrhosis" (1 trials), "ESRD" (1 trials) and "Esophagus Cancer" (1 trials). Many other conditions were trialed in "Ningbo No.2 Hospital" in a lesser frequency.

Most popular intervention types in "Ningbo No.2 Hospital" are "Drug" (7 trials), "Procedure" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "FG-4592" (2 trials), "3 cycles of Neoadjuvant Chemotherapy With concurrent chemoradiotherapy" (1 trials), "4 cycles of Neoadjuvant Chemotherapy With Definitive Radiotherapy" (1 trials), "4mg ZOL loaded gentamicin PMMA" (1 trials) and "Aegisy Vena Cava Filter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ningbo No.2 Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Ningbo No.2 Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ningbo No.2 Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ningbo No.2 Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".